Navigant Acquires Dymedex Consulting to Expand its Life Sciences Practice

Navigant has acquired Dymedex Consulting LLC, a Minnesota-based firm that provides data-driven market analysis to accelerate adoption and maximize growth for medical device companies. Dymedex offers insights through global strategic market assessments, tactical geography planning, and market landscape analysis.
 
The addition of the Dymedex team, as well as the firm’s proprietary market development tools and methodologies, expands Navigant’s capabilities in the medical technology and life sciences industries, the company claims. Navigant also plans to make the Dymedex tools, methodologies and expertise available to its healthcare clients.
 
“In today’s medical device market, it is critical that companies create the conditions necessary to optimize growth, utilization, and adoption. Dymedex has a proven methodology to assist companies in accelerating the development of global markets,” said Eduardo Schur, managing director and Global Life Sciences practice leader at Navigant. “And while Dymedex has been successful in the medical technology field, we are excited by the opportunity to expand their methodologies into other life sciences areas such as pharmaceuticals and biotech.”
 
The Dymedex team, including founders Joseph Galatowitsch and Ross Meisner, will join the Navigant Life Sciences practice within the company’s healthcare segment.

“Uncovering critical market insights and facilitating data-driven decisions is vital to the success of life science and medtech companies,” said Joseph Galatowitsch, co-founder of Dymedex Consulting and managing director at Navigant. “The combination of Dymedex’s proprietary tools and methodologies with Navigant’s industry expertise and global footprint will enable our clients to fully capitalize on their opportunities.”
 
Based in Minneapolis, Dymedex has evaluated more than 100 different medical technologies for their clients and worked in nearly 20 countries around the world. With knowledge of the challenges clients face, Dymedex helps clients address complex problems across multiple therapeutic and clinical areas and works on a wide range of medical technologies and business models, including monitoring and diagnostic products, therapies of all types, surgical tools, disposables, capital equipment, and other complex or combination devices.
 
Navigant Consulting Inc. is a specialized, global professional services firm that helps clients build, manage and/or protect their business interests. With a focus on markets and clients facing transformational change and significant regulatory or legal pressures, the firm primarily serves clients in the healthcare, energy and financial services industries.

Dymedex is a market development consulting firm that helps medical technology companies reach full market potential by using data-driven market analysis and insight to improve decision-making. Dymedex has developed more than 100 customized medical technology market development plans in all major markets globally. Dymedex relies on more than 80 years of combined experience that includes nearly every major disease and condition.